#ASGCT26: After an apparent cure, a gene editing company struggles to repeat the magic
BOSTON — Early last year, startup iECURE’s experimental gene therapy seemingly cured a baby of a life-threatening genetic disease. But new results testing the same therapy in a larger number of babies show ...
Jim Wilson, iECURE scientific advisor (Credit: GEMMABio) May 13, 2026 02:50 PM EDT StartupsR&DCell/Gene Tx After an apparent cure, a gene editing company struggles to repeat the magic Ryan Cross Senior Science Correspondent BOSTON — Early last year, startup iECURE’s experimental gene therapy seemingly cured a baby of a life-threatening genetic disease. But new results testing … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that